Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Salamanca
Clinical trial register · Spain

Clinical Trials in Salamanca, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5925 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
5925
Studies in scope
all four open statuses
3119
Recruiting now
open to new participants
1134
Lead sponsors
across recruiting studies
Top sites
Madrid 16 Barcelona 15 Salamanca 7 Seville 7 Majadahonda 6

Trials with a site in Salamanca

7 of 5925 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
NCT07709000Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies
Merck Sharp & Dohme LLC
Phase 2
60
Madrid, Salamanca
2026-10-14
Recruiting
BeOne Medicines
Phase 3
630
Barcelona, LHospitalet de Llobregat, Madrid, Marbella, Salamanca, Santander, Seville
2025-06-11
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, Marbella, Oviedo, Salamanca, Santander
2025-01-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
L'Hospitalet Del Llobregat, Barcelona, Pozuelo de Alarcón, Majadahonda, San Cristóbal de La Laguna, Salamanca
2023-12-13
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 1/2
218
Badalona, L'Hospitalet de Llobregat, Barcelona, Córdoba, Madrid, Salamanca, Seville, Valencia
2019-06-26
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Cellectar Biosciences, Inc.
Phase 2
120
Barcelona, Madrid, Salamanca, Zaragoza
2017-07-26
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
539
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca
2013-09-09
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-spain/city/salamanca

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,925 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Salamanca that also match the filters currently applied.

How many clinical trials are recruiting in Salamanca?

4 of the 7 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Salamanca), 7 studies
PhaseStudiesRecruitingShare
Phase 23242.9%
Phase 33242.9%
Phase 1/21014.3%

Most active sponsors

Lead sponsors with the most studies (Salamanca)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC22
BeOne Medicines11
Cellectar Biosciences, Inc.10
Janssen Research & Development, LLC10
Loxo Oncology, Inc.11
Novartis Pharmaceuticals10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.